Featured
Obstetrics and Gynecology Journal: Published in September, 2022Vaccination against coronavirus
disease 2019 is safe and effective at preventing illness, including hospitalization
and death due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections,
and booster and additional primary dose COVID-19 vaccinations increase
protec...
The New England Journal of Medicine
TAKE-HOME MESSAGE
This retrospective study evaluated
the effectiveness of the Pfizer (BNT162b2) COVID-19 vaccine in preventing
reinfection in patients who had recovered from COVID-19.
A total of 149,039 patients who had
recovered from COVID-19 were included, and, of these, 56% were subsequently...
FDA authorized the emergency use of the Pfizer-BioNTech
COVID-19 Vaccine for the prevention of COVID19 to include
children 5 through 11 years of age.
Key points:
Effectiveness: Immune responses of
children 5 through 11 years of age were comparable to those of individuals
16 through 25 years of age. In addition, t...
A study by the University of
Oxford, published in the journal Cell, demonstrates that currently
available vaccines, including AstraZeneca’s COVID-19 vaccine, will provide
protection against the Delta (B.1.617.2) and Kappa (B1.617.1) variants;
formerly the ‘Indian’ variants.
The study, investigated the
ability of antibodies in the blood of...
Food and Drug Administration
advisory committee (US FDA) unanimously recommend the third shots to people age
65 and older and those at a high risk of suffering from severe illness if they
get the coronavirus.
Rejected a proposal to distribute
booster/third shots of Pfizer and BioNTech’s Covid-19 vaccine to the General Public. RemoveA...
Oxford researchers say having
AstraZeneca then Pfizer vaccine is almost as potent as two shots of Pfizer.Scientists in Oxford looked at
the impact of a mix-and-match approach to vaccinations where people were given
either the standard two shots of Oxford/AstraZeneca or Pfizer/BioNTech
vaccine, or a combination of the two. Mixed schedules involv...
A two-dose regimen of Pfizer vaccine conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines.
The basis of upcoming Pfizer and Moderna coronavirus vaccines. How it works?
It’s a two-shot vaccine, so
what happens if people miss their second shot? Is a single shot still
protective?
The Pfizer-BioNTech vaccine requires two injections, given 21 days apart,
to prime the immune system well enough to fight off the coronavirus.
Two shots are needed, and the second shot is required to...
PFIZER AND BIONTECH VACCINE TO
COMBAT COVID-19
What is in the vaccine?
the Pfizer-BioNTech vaccine is based on the virus’s genetic instructions for
building the spike protein. The technology relies on a small piece of messenger
RNA (mRNA) from the coronavirus genome. It delivers a gene that codes for the
coronavirus'...
The German company BioNTech
partnered with Pfizer to develop and test a coronavirus vaccine known as
BNT162b2. The mRNA technology, short for messenger RNA vaccines like Pfizer's
are often referred to as the vaccines of the future, since the technology is
fairly new.
·
The active ingredient is messenger RN...
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 StudyVaccine
candidate was found to be more than 90% effective in preventing
COVID-19 in participants without evidence of prior SARS-CoV-2 infection
in the first interim efficacy analysisAnalysis evaluated 94 confirmed cases...